demonstrated, in addition to higher weight loss in the group treated with high-dose liraglutide 3.0 mg/day for 32 weeks, significant improvements not only of fasting glucose and HOMA-IR, but also of the post-load glucose measured by OGTT, OGTT-derived insulin sensitivity index (SIOGTT), and corrected the early insulin response to a glucose challenge (IGI/HOMA) compared to placebo [62]
Its a maze of narrow streets and impossible parking
In the Indian context, given our diversity and unique obesity signature, the promise is lofty but conditional, at best
The antimicrobial mechanisms may involve the inhibition of key bacterial enzymes, such as DNA gyrase and topoisomerase, thereby disrupting DNA replication and transcription to suppress bacterial growth
Our technical team includes metabolic researchers who understand GIP, GLP-1, and glucagon pathway interactions